1. 1) Maurer HM, Moon T, Donaldson M, et al. : The intergroup rhabdomyosarcoma study: a preliminary report. Cancer 40: 2015-2026, 1977.
2. 2) Saylors RL 3rd, Stine KC, Sullivan J, et al. : Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 19: 3463-3469, 2001.
3. 3) Enzinger FM and Weiss SW : Rhabdomyosarcoma. Soft tissue tumors (ed by Stamathis G). pp 448-488, the C.V. Mosby company, St. Louis, 1988.
4. 4) Healy GB, Upton J, Black PM, et al. : The role of surgery in rhabdomyosarcoma of the head and neck in children. Arch Otolaryngol Head Neck Surg 117: 1185-1188, 1991.
5. 5) Crist WM, Garnsey L, Beltangady MS, et al. : Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 8: 443-452, 1990.